Free Trial

Xerox (XRX) Financials

Xerox logo
$3.98 +0.08 (+2.05%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$3.96 -0.02 (-0.63%)
As of 08/29/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Xerox

Annual Income Statements for Xerox

This table shows Xerox's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
195 361 3,528 192 -469 -336 -13 -1,335
Consolidated Net Income / (Loss)
207 374 1,361 192 -455 -322 1.00 -1,321
Net Income / (Loss) Continuing Operations
70 310 651 192 -455 -322 1.00 -1,321
Total Pre-Tax Income
525 549 822 252 -472 -325 -28 -1,216
Total Operating Income
525 549 1,728 252 -472 -325 -28 -1,216
Total Gross Profit
4,071 3,869 12,716 2,626 2,514 2,426 2,314 2,066
Total Revenue
9,991 9,662 18,132 7,022 7,038 7,107 6,886 6,221
Operating Revenue
9,991 9,662 18,132 7,022 7,038 7,107 6,886 6,221
Total Cost of Revenue
5,920 5,793 5,416 4,396 4,524 4,681 4,572 4,155
Operating Cost of Revenue
5,920 5,793 5,416 4,396 4,524 4,681 4,572 4,155
Total Operating Expenses
3,546 3,320 10,988 2,374 2,986 2,751 2,342 3,282
Selling, General & Admin Expense
2,514 2,379 2,458 1,851 1,718 1,760 1,696 1,537
Research & Development Expense
424 397 - 311 310 304 229 191
Amortization Expense
53 48 45 56 55 42 43 73
Other Operating Expenses / (Income)
339 339 8,256 63 84 168 207 311
Impairment Charge
- - 0.00 0.00 781 412 0.00 1,058
Restructuring Charge
216 157 229 93 38 65 167 112
Total Other Income / (Expense), net
0.00 0.00 -84 0.00 0.00 0.00 0.00 0.00
Income Tax Expense
468 247 179 64 -17 -3.00 -29 105
Preferred Stock Dividends Declared
- - - - 14 14 14 14
Basic Earnings per Share
$0.71 $1.40 $8.89 $0.85 ($2.56) ($2.15) ($0.09) ($10.75)
Weighted Average Basic Shares Outstanding
- - 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M
Diluted Earnings per Share
$0.71 $1.38 $5.80 $0.84 ($2.56) ($2.15) ($0.09) ($10.75)
Weighted Average Diluted Shares Outstanding
- - 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M
Weighted Average Basic & Diluted Shares Outstanding
- - 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M
Cash Dividends to Common per Share
- $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00

Quarterly Income Statements for Xerox

This table shows Xerox's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-383 107 67 -64 45 -61 -117 15 -1,209 -24 -94
Consolidated Net Income / (Loss)
-382 122 71 -61 49 -58 -113 18 -1,205 -21 -90
Net Income / (Loss) Continuing Operations
-382 122 71 -61 49 -58 -113 18 -1,205 -21 -90
Total Pre-Tax Income
-380 149 85 -89 64 -88 -150 25 -1,087 -4.00 -67
Total Operating Income
-380 149 85 -89 64 -88 -150 25 -1,087 -4.00 -67
Total Gross Profit
556 757 589 631 566 528 443 549 495 579 426
Total Revenue
1,751 1,941 1,715 1,754 1,652 1,765 1,502 1,578 1,528 1,613 1,457
Operating Revenue
1,751 1,941 1,715 1,754 1,652 1,765 1,502 1,578 1,528 1,613 1,457
Total Cost of Revenue
1,195 1,184 1,126 1,123 1,086 1,237 1,059 1,029 1,033 1,034 1,031
Operating Cost of Revenue
1,195 1,184 1,126 1,123 1,086 1,237 1,059 1,029 1,033 1,034 1,031
Total Operating Expenses
936 608 504 720 502 616 593 524 1,582 583 493
Selling, General & Admin Expense
418 428 407 433 416 440 397 393 370 377 378
Research & Development Expense
73 69 64 57 52 56 49 50 45 47 42
Amortization Expense
10 11 11 10 12 10 10 10 10 43 10
Other Operating Expenses / (Income)
1.00 76 20 197 12 -22 98 59 43 111 64
Restructuring Charge
22 24 2.00 23 10 132 39 12 56 5.00 -1.00
Total Other Income / (Expense), net
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Income Tax Expense
3.00 24 14 -28 15 -30 -37 7.00 118 17 23
Preferred Stock Dividends Declared
- - 4.00 3.00 4.00 3.00 4.00 3.00 4.00 3.00 4.00
Basic Earnings per Share
($2.48) $0.76 $0.43 ($0.41) $0.29 ($0.40) ($0.94) $0.12 ($9.71) ($0.22) ($0.75)
Weighted Average Basic Shares Outstanding
155.60M 156.43M 156.96M 157.12M 122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M
Diluted Earnings per Share
($2.48) $0.76 $0.43 ($0.41) $0.28 ($0.39) ($0.94) $0.11 ($9.71) ($0.21) ($0.75)
Weighted Average Diluted Shares Outstanding
155.60M 156.43M 156.96M 157.12M 122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M
Weighted Average Basic & Diluted Shares Outstanding
155.60M 156.43M 156.96M 157.12M 122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M
Cash Dividends to Common per Share
$0.25 - $0.25 $0.25 $0.25 - $0.25 $0.25 $0.25 - $0.13

Annual Cash Flow Statements for Xerox

This table details how cash moves in and out of Xerox's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-2,041 -2.00 1,647 -104 -782 -770 -522 14
Net Cash From Operating Activities
-534 2,280 1,333 548 629 159 686 511
Net Cash From Continuing Operating Activities
-498 2,164 1,244 548 629 159 686 511
Net Income / (Loss) Continuing Operations
140 620 651 192 -455 -322 1.00 -1,321
Consolidated Net Income / (Loss)
414 748 1,361 192 -455 -322 1.00 -1,321
Depreciation Expense
1,054 1,052 430 368 327 270 251 274
Non-Cash Adjustments To Reconcile Net Income
1,002 846 533 53 619 422 264 1,281
Changes in Operating Assets and Liabilities, net
-2,260 142 12 -65 138 -211 170 277
Net Cash From Investing Activities
330 -58 2,148 -246 -85 -78 -5.00 -198
Net Cash From Continuing Investing Activities
330 -58 -85 -246 -85 -78 -5.00 -198
Purchase of Property, Plant & Equipment
-210 -180 65 -74 -68 -57 -37 -44
Acquisitions
-174 0.00 42 -203 -53 -93 -7.00 -161
Divestitures
- - - 30 44 87 43 35
Other Investing Activities, net
413 4.00 20 1.00 -8.00 -15 -4.00 -28
Net Cash From Financing Activities
-1,970 -2,602 -1,834 -416 -1,310 -822 -1,202 -271
Net Cash From Continuing Financing Activities
-1,970 -2,602 -1,834 -416 -1,310 -822 -1,202 -271
Repayment of Debt
-3,408 -672 919 -2,245 -527 -1,729 -1,889 -1,006
Repurchase of Common Equity
0.00 -1,400 600 -300 -888 -113 -544 -8.00
Payment of Dividends
-582 -538 243 -230 -206 -174 -165 -141
Issuance of Debt
2,020 8.00 10 2,359 311 1,194 1,396 907
Other Financing Activities, net
- 0.00 - - - 0.00 0.00 -23
Effect of Exchange Rate Changes
- - - 10 -16 -29 -1.00 -28

Quarterly Cash Flow Statements for Xerox

This table details how cash moves in and out of Xerox's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
-226 138 -442 -128 48 - 155 -221 39 41 -241
Net Cash From Operating Activities
-8.00 186 78 95 124 389 -79 123 116 351 -89
Net Cash From Continuing Operating Activities
-8.00 186 78 95 124 389 -79 123 116 351 -89
Net Income / (Loss) Continuing Operations
-382 122 71 -61 49 -58 -113 18 -1,205 -21 -90
Consolidated Net Income / (Loss)
-382 122 71 -61 49 -58 -113 18 -1,205 -21 -90
Depreciation Expense
65 65 64 62 63 62 59 59 59 97 60
Non-Cash Adjustments To Reconcile Net Income
403 -4.00 -3.00 174 -35 128 146 37 1,093 5.00 6.00
Changes in Operating Assets and Liabilities, net
-94 3.00 -54 -80 47 257 -171 9.00 169 270 -65
Net Cash From Investing Activities
-33 17 -17 -5.00 25 -8.00 -17 -2.00 -7.00 -172 6.00
Net Cash From Continuing Investing Activities
-33 17 -17 -5.00 25 -8.00 -17 -2.00 -7.00 -172 6.00
Purchase of Property, Plant & Equipment
-10 -18 -8.00 -7.00 -12 -10 -10 -8.00 -9.00 -17 -20
Acquisitions
-41 - -7.00 - - - 0.00 - - -161 1.00
Divestitures
23 38 1.00 2.00 37 3.00 4.00 15 8.00 8.00 27
Other Investing Activities, net
-5.00 -3.00 -3.00 - - -1.00 -11 -9.00 -6.00 -2.00 -2.00
Net Cash From Financing Activities
-168 -67 -505 -220 -94 -383 261 -336 -74 -122 -159
Net Cash From Continuing Financing Activities
-168 -67 -505 -220 -94 -383 261 -336 -74 -122 -159
Repayment of Debt
-125 -464 -460 -177 -373 -879 -581 -303 -38 -84 -123
Repurchase of Common Equity
- - 0.00 - -544 - -3.00 - - -5.00 0.00
Payment of Dividends
-43 -43 -45 -43 -43 -34 -37 -34 -36 -34 -39
Issuance of Debt
- 440 0.00 - 866 530 905 1.00 - 1.00 3.00
Other Financing Activities, net
- - 0.00 - - - -23 - - - 0.00
Effect of Exchange Rate Changes
-17 2.00 2.00 2.00 -7.00 2.00 -10 -6.00 4.00 -16 1.00

Annual Balance Sheets for Xerox

This table presents Xerox's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
29,748 30,094 14,741 13,223 11,543 10,008 8,365
Total Current Assets
9,426 12,280 5,783 4,701 4,107 3,177 2,935
Cash & Equivalents
2,162 5,480 2,625 1,840 1,045 519 576
Note & Lease Receivable
2,646 2,538 1,181 1,136 1,154 913 656
Accounts Receivable
2,540 2,472 883 818 857 850 796
Inventories, net
1,658 1,388 843 696 797 661 695
Other Current Assets
382 402 251 211 254 234 212
Plant, Property, & Equipment, net
1,880 0.00 407 358 320 266 251
Plant, Property & Equipment, gross
- - 407 358 320 266 251
Total Noncurrent Assets
18,442 16,234 8,551 8,164 7,116 6,565 5,179
Noncurrent Note & Lease Receivables
4,298 4,164 1,984 1,934 1,948 1,597 1,089
Goodwill
7,716 7,800 4,071 3,287 2,820 2,747 1,937
Intangible Assets
440 398 237 211 208 177 236
Noncurrent Deferred & Refundable Income Taxes
1,480 1,196 508 519 582 745 615
Other Noncurrent Operating Assets
1,804 2,676 1,751 2,213 1,558 1,299 1,302
Total Liabilities & Shareholders' Equity
29,748 30,094 14,741 13,223 11,543 10,008 8,365
Total Liabilities
19,242 18,412 8,931 8,556 7,966 7,236 7,061
Total Current Liabilities
6,502 6,804 2,478 2,829 3,330 2,779 2,619
Short-Term Debt
1,922 - 394 650 860 567 585
Accounts Payable
2,146 2,106 983 1,069 1,331 1,044 1,023
Accrued Expenses
- - - 871 881 862 784
Current Employee Benefit Liabilities
696 698 261 239 258 306 227
Total Noncurrent Liabilities
12,740 8,375 6,453 5,727 4,636 4,457 4,442
Long-Term Debt
8,538 3,233 4,050 3,596 2,866 2,710 2,814
Noncurrent Employee Benefit Liabilities
3,664 4,118 1,906 1,650 1,359 1,387 1,242
Other Noncurrent Operating Liabilities
538 1,024 497 481 411 360 386
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
428 214 214 224 224 224 224
Total Equity & Noncontrolling Interests
10,078 11,468 5,596 4,443 3,353 2,548 1,080
Total Preferred & Common Equity
10,010 11,454 5,592 4,436 3,343 2,538 1,076
Total Common Equity
10,010 11,454 5,592 4,436 3,343 2,538 1,076
Common Stock
7,106 6,263 2,643 1,970 1,744 1,237 1,261
Retained Earnings
10,144 12,559 6,281 5,631 5,136 4,977 3,514
Accumulated Other Comprehensive Income / (Loss)
-7,130 -7,292 -3,332 -2,988 -3,537 -3,676 -3,699
Noncontrolling Interest
68 14 4.00 7.00 10 10 4.00

Quarterly Balance Sheets for Xerox

This table presents Xerox's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets
11,420 11,046 10,569 10,444 9,944 9,491 8,322 8,211
Total Current Assets
3,895 3,640 3,390 3,354 3,348 3,051 3,011 2,867
Cash & Equivalents
932 591 477 532 685 485 521 336
Note & Lease Receivable
1,086 1,116 1,010 986 850 783 714 626
Accounts Receivable
835 818 903 880 846 847 821 819
Inventories, net
777 863 782 728 736 737 732 836
Other Current Assets
265 252 218 228 231 199 223 250
Plant, Property, & Equipment, net
315 311 281 273 245 227 225 195
Plant, Property & Equipment, gross
315 311 281 273 245 227 225 195
Total Noncurrent Assets
7,210 7,095 6,898 6,817 6,351 6,213 5,086 5,149
Noncurrent Note & Lease Receivables
1,814 1,864 1,697 1,605 1,408 1,277 1,275 1,013
Goodwill
2,753 2,850 2,751 2,716 2,720 2,719 1,709 1,954
Intangible Assets
216 202 194 183 165 155 149 228
Noncurrent Deferred & Refundable Income Taxes
496 598 620 701 749 760 635 607
Other Noncurrent Operating Assets
1,931 1,581 1,636 1,612 1,309 1,302 1,318 1,347
Total Liabilities & Shareholders' Equity
11,420 11,046 10,569 10,444 9,944 9,491 8,322 8,211
Total Liabilities
7,942 7,355 6,953 7,422 7,339 6,902 6,791 6,930
Total Current Liabilities
3,343 2,879 2,949 3,006 2,438 2,046 2,393 2,639
Short-Term Debt
1,070 553 891 870 405 129 519 599
Accounts Payable
1,213 1,301 1,041 1,031 1,046 936 895 1,120
Accrued Expenses
810 782 766 829 774 776 752 721
Current Employee Benefit Liabilities
250 243 251 276 213 205 227 199
Total Noncurrent Liabilities
4,599 4,476 4,004 4,416 4,901 4,856 4,398 4,291
Long-Term Debt
2,676 2,726 2,225 2,739 3,199 3,174 2,752 2,699
Noncurrent Employee Benefit Liabilities
1,507 1,350 1,385 1,306 1,350 1,344 1,292 1,229
Other Noncurrent Operating Liabilities
416 400 394 371 352 338 354 363
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
224 224 224 224 214 224 224 224
Total Equity & Noncontrolling Interests
3,254 3,467 3,392 2,798 2,381 2,365 1,307 1,057
Total Preferred & Common Equity
3,243 3,459 3,384 2,789 2,378 2,361 1,303 1,053
Total Common Equity
3,243 3,459 3,384 2,789 2,378 2,361 1,303 1,053
Common Stock
1,733 1,751 1,764 1,776 1,223 1,238 1,247 1,267
Retained Earnings
5,057 5,162 5,057 5,070 4,828 4,810 3,570 3,403
Accumulated Other Comprehensive Income / (Loss)
-3,547 -3,454 -3,437 -3,504 -3,673 -3,687 -3,514 -3,617
Noncontrolling Interest
11 8.00 8.00 9.00 3.00 4.00 4.00 4.00

Annual Metrics And Ratios for Xerox

This table displays calculated financial ratios and metrics derived from Xerox's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% -3.29% 87.66% -61.27% 0.23% 0.98% -3.11% -9.66%
EBITDA Growth
0.00% 1.39% 29.54% -70.11% -123.39% 62.07% 505.45% -522.42%
EBIT Growth
0.00% 4.57% 199.45% -84.67% -287.30% 31.14% 91.38% -4,242.86%
NOPAT Growth
0.00% 429.82% 347.59% -86.09% -275.74% 31.14% 91.38% -4,242.86%
Net Income Growth
0.00% 80.68% 263.90% -85.89% -336.98% 29.23% 100.31% -132,200.00%
EPS Growth
0.00% 94.37% 320.29% -85.52% -404.76% 16.02% 95.81% -11,844.44%
Operating Cash Flow Growth
0.00% 526.97% -41.54% -58.89% 14.78% -74.72% 331.45% -25.51%
Free Cash Flow Firm Growth
0.00% 0.00% 127.02% 34.55% -96.07% 160.42% 20.58% -22.11%
Invested Capital Growth
0.00% 0.00% -18.12% -42.14% -7.29% -11.52% -11.63% -25.37%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -57.70% -2.13% 2.36% -2.49% -2.39%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -56.61% -121.20% 93.88% -51.84% 11.22%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -81.88% -239.23% 72.50% -113.40% 6.46%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -82.57% -213.15% 72.50% -110.65% 6.46%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -79.44% -253.72% 71.20% -99.45% 2.72%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% -274.15% 67.37% -108.49% 1.65%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -49.12% 480.56% -5.56% -7.02% 42.03% -6.92%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -96.77% 43.43% 87.90% -39.23%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -46.33% -6.06% -0.54% -9.33% -3.60%
Profitability Metrics
- - - - - - - -
Gross Margin
40.75% 40.04% 70.13% 37.40% 35.72% 34.14% 33.60% 33.21%
EBITDA Margin
15.80% 16.57% 11.44% 8.83% -2.06% -0.77% 3.24% -15.14%
Operating Margin
5.25% 5.68% 9.53% 3.59% -6.71% -4.57% -0.41% -19.55%
EBIT Margin
5.25% 5.68% 9.07% 3.59% -6.71% -4.57% -0.41% -19.55%
Profit (Net Income) Margin
2.07% 3.87% 7.51% 2.73% -6.46% -4.53% 0.01% -21.23%
Tax Burden Percent
39.43% 68.12% 165.57% 76.19% 96.40% 99.08% -3.57% 108.63%
Interest Burden Percent
100.00% 100.00% 50.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
89.14% 44.99% 21.78% 25.40% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 3.75% 9.23% 1.81% -4.49% -3.41% -0.33% -17.63%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 6.32% 9.49% 2.05% -10.39% -7.13% 0.43% -34.46%
Return on Net Nonoperating Assets (RNNOA)
0.00% 3.37% 3.04% 0.39% -4.19% -4.40% 0.36% -47.19%
Return on Equity (ROE)
0.00% 7.12% 12.27% 2.20% -8.69% -7.81% 0.03% -64.82%
Cash Return on Invested Capital (CROIC)
0.00% -196.25% 29.15% 55.20% 3.07% 8.81% 12.02% 11.43%
Operating Return on Assets (OROA)
0.00% 1.85% 5.49% 1.12% -3.38% -2.62% -0.26% -13.24%
Return on Assets (ROA)
0.00% 1.26% 4.55% 0.86% -3.25% -2.60% 0.01% -14.38%
Return on Common Equity (ROCE)
0.00% 6.78% 11.87% 2.14% -8.31% -7.37% 0.03% -57.47%
Return on Equity Simple (ROE_SIMPLE)
0.00% 3.74% 11.88% 3.43% -10.26% -9.63% 0.04% -122.77%
Net Operating Profit after Tax (NOPAT)
57 302 1,352 188 -330 -228 -20 -851
NOPAT Margin
0.57% 3.13% 7.45% 2.68% -4.69% -3.20% -0.28% -13.68%
Net Nonoperating Expense Percent (NNEP)
0.00% -2.57% -0.26% -0.24% 5.90% 3.72% -0.76% 16.84%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -3.21% -0.34% -19.00%
Cost of Revenue to Revenue
59.25% 59.96% 29.87% 62.60% 64.28% 65.86% 66.40% 66.79%
SG&A Expenses to Revenue
25.16% 24.62% 13.56% 26.36% 24.41% 24.76% 24.63% 24.71%
R&D to Revenue
4.24% 4.11% 0.00% 4.43% 4.40% 4.28% 3.33% 3.07%
Operating Expenses to Revenue
35.49% 34.36% 60.60% 33.81% 42.43% 38.71% 34.01% 52.76%
Earnings before Interest and Taxes (EBIT)
525 549 1,644 252 -472 -325 -28 -1,216
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,579 1,601 2,074 620 -145 -55 223 -942
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.54 0.67 0.78 0.58 0.81 0.97
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.89 2.92 3.67 6.20 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.34 0.53 0.49 0.27 0.30 0.17
Price to Earnings (P/E)
0.00 0.00 1.74 19.52 0.00 0.00 0.00 0.00
Dividend Yield
4.77% 6.76% 3.51% 5.29% 5.19% 7.97% 5.95% 11.86%
Earnings Yield
0.00% 0.00% 57.36% 5.12% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.31 0.76 0.86 0.78 0.91 0.99
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.23 0.82 0.86 0.69 0.73 0.66
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 1.99 9.33 0.00 0.00 22.68 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 2.51 22.95 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 3.06 30.77 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 3.10 10.56 9.66 30.62 7.37 8.02
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.97 1.01 26.93 8.29 7.14 7.43
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 1.00 0.28 0.76 0.91 1.04 1.18 2.61
Long-Term Debt to Equity
0.00 0.81 0.28 0.70 0.77 0.80 0.98 2.16
Financial Leverage
0.00 0.53 0.32 0.19 0.40 0.62 0.86 1.37
Leverage Ratio
0.00 2.83 2.70 2.56 2.67 3.00 3.39 4.51
Compound Leverage Factor
0.00 2.83 1.35 2.56 2.67 3.00 3.39 4.51
Debt to Total Capital
0.00% 49.89% 21.68% 43.34% 47.64% 51.02% 54.17% 72.27%
Short-Term Debt to Total Capital
0.00% 9.17% 0.00% 3.84% 7.29% 11.78% 9.37% 12.44%
Long-Term Debt to Total Capital
0.00% 40.72% 21.68% 39.50% 40.35% 39.24% 44.80% 59.83%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.37% 1.53% 2.13% 2.59% 3.20% 3.87% 4.85%
Common Equity to Total Capital
0.00% 47.74% 76.80% 54.53% 49.77% 45.78% 41.96% 22.88%
Debt to EBITDA
0.00 6.53 1.56 7.17 -29.28 -67.75 14.70 -3.61
Net Debt to EBITDA
0.00 5.18 -1.08 2.93 -16.59 -48.75 12.37 -3.00
Long-Term Debt to EBITDA
0.00 5.33 1.56 6.53 -24.80 -52.11 12.15 -2.99
Debt to NOPAT
0.00 34.64 2.39 23.64 -12.85 -16.38 -167.19 -3.99
Net Debt to NOPAT
0.00 27.48 -1.66 9.68 -7.28 -11.78 -140.71 -3.32
Long-Term Debt to NOPAT
0.00 28.27 2.39 21.54 -10.88 -12.60 -138.27 -3.31
Altman Z-Score
0.00 0.00 1.79 1.65 1.42 1.37 1.59 0.99
Noncontrolling Interest Sharing Ratio
0.00% 4.72% 3.26% 2.55% 4.29% 5.64% 7.37% 11.33%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 1.45 1.80 2.33 1.66 1.23 1.14 1.12
Quick Ratio
0.00 1.13 1.54 1.89 1.34 0.92 0.82 0.77
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -15,802 4,270 5,745 226 588 708 552
Operating Cash Flow to CapEx
-254.29% 1,266.67% 0.00% 740.54% 925.00% 278.95% 1,854.05% 1,161.36%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.32 0.61 0.31 0.50 0.57 0.64 0.68
Accounts Receivable Turnover
0.00 3.80 7.24 4.19 8.28 8.49 8.07 7.56
Inventory Turnover
0.00 3.49 3.56 3.94 5.88 6.27 6.27 6.13
Fixed Asset Turnover
0.00 5.14 0.00 0.00 18.40 20.96 23.50 24.07
Accounts Payable Turnover
0.00 2.70 2.55 2.85 4.41 3.90 3.85 4.02
Days Sales Outstanding (DSO)
0.00 95.95 50.45 87.20 44.11 43.01 45.24 48.29
Days Inventory Outstanding (DIO)
0.00 104.47 102.64 92.62 62.08 58.21 58.20 59.56
Days Payable Outstanding (DPO)
0.00 135.21 143.28 128.24 82.78 93.57 94.80 90.79
Cash Conversion Cycle (CCC)
0.00 65.21 9.81 51.58 23.41 7.65 8.64 17.06
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 16,104 13,186 7,629 7,073 6,258 5,530 4,127
Invested Capital Turnover
0.00 1.20 1.24 0.67 0.96 1.07 1.17 1.29
Increase / (Decrease) in Invested Capital
0.00 16,104 -2,918 -5,557 -556 -815 -728 -1,403
Enterprise Value (EV)
0.00 0.00 4,132 5,784 6,076 4,868 5,057 4,099
Market Capitalization
0.00 0.00 6,151 3,747 3,439 1,953 2,065 1,048
Book Value per Share
$0.00 $0.00 $52.98 $28.19 $24.85 $21.48 $20.65 $8.65
Tangible Book Value per Share
$0.00 $0.00 $15.06 $6.47 $5.25 $2.02 ($3.14) ($8.82)
Total Capital
0.00 20,966 14,915 10,254 8,913 7,303 6,049 4,703
Total Debt
0.00 10,460 3,233 4,444 4,246 3,726 3,277 3,399
Total Long-Term Debt
0.00 8,538 3,233 4,050 3,596 2,866 2,710 2,814
Net Debt
0.00 8,298 -2,247 1,819 2,406 2,681 2,758 2,823
Capital Expenditures (CapEx)
210 180 -65 74 68 57 37 44
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 2,684 -4.00 1,074 682 592 446 325
Debt-free Net Working Capital (DFNWC)
0.00 4,846 5,476 3,699 2,522 1,637 965 901
Net Working Capital (NWC)
0.00 2,924 5,476 3,305 1,872 777 398 316
Net Nonoperating Expense (NNE)
-150 -72 -9.29 -4.00 125 95 -21 470
Net Nonoperating Obligations (NNO)
0.00 5,598 1,504 1,819 2,406 2,681 2,758 2,823
Total Depreciation and Amortization (D&A)
1,054 1,052 430 368 327 270 251 274
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 27.78% -0.02% 15.29% 9.69% 8.33% 6.48% 5.22%
Debt-free Net Working Capital to Revenue
0.00% 50.16% 30.20% 52.68% 35.83% 23.03% 14.01% 14.48%
Net Working Capital to Revenue
0.00% 30.26% 30.20% 47.07% 26.60% 10.93% 5.78% 5.08%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.85 ($5.12) ($2.15) ($0.09) ($10.75)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.84 ($2.56) ($2.15) ($0.09) ($10.75)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 212.79M 198.65M 156.35M 156.43M 124.18M 125.28M
Normalized Net Operating Profit after Tax (NOPAT)
519 388 1,531 257 243 106 97 -32
Normalized NOPAT Margin
5.19% 4.02% 8.44% 3.67% 3.45% 1.50% 1.41% -0.52%
Pre Tax Income Margin
5.25% 5.68% 4.53% 3.59% -6.71% -4.57% -0.41% -19.55%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
281.16% 143.85% -17.85% 119.79% -45.27% -54.04% 16,500.00% -10.67%
Augmented Payout Ratio
281.16% 518.18% -61.94% 276.04% -240.44% -89.13% 70,900.00% -11.28%

Quarterly Metrics And Ratios for Xerox

This table displays calculated financial ratios and metrics derived from Xerox's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.40% 9.23% 2.82% 0.40% -5.65% -9.07% -12.42% -10.03% -7.51% -8.61% -3.00%
EBITDA Growth
-293.25% 133.97% 976.47% -142.86% 140.32% -112.15% -161.07% 411.11% -909.45% 457.69% 92.31%
EBIT Growth
-552.38% 121.05% 195.51% -1,680.00% 116.84% -159.06% -276.47% 128.09% -1,798.44% 95.45% 55.33%
NOPAT Growth
-402.27% 125.22% 213.96% -1,680.00% 118.42% -149.28% -247.89% 128.89% -1,652.86% 95.45% 55.33%
Net Income Growth
-529.21% 118.10% 224.56% -1,120.00% 112.83% -147.54% -259.15% 129.51% -2,559.18% 63.79% 20.35%
EPS Growth
-616.67% 120.65% 213.16% -720.00% 111.29% -151.32% -318.60% 126.83% -3,567.86% 46.15% 20.21%
Operating Cash Flow Growth
-108.00% -6.06% 18.18% 211.76% 1,650.00% 109.14% -201.28% 29.47% -6.45% -9.77% -12.66%
Free Cash Flow Firm Growth
-85.66% 1,456.29% -90.65% -35.77% -75.08% -29.11% 7.91% 69.90% 336.82% 110.11% 64.55%
Invested Capital Growth
-16.43% -11.52% -8.91% -8.38% -3.07% -11.63% -13.40% -13.56% -29.81% -25.37% -23.19%
Revenue Q/Q Growth
0.23% 10.85% -11.64% 2.27% -5.82% 6.84% -14.90% 5.06% -3.17% 5.56% -9.67%
EBITDA Q/Q Growth
-600.00% 167.94% -30.37% -118.12% 570.37% -120.47% -264.00% 192.31% -1,323.81% 109.05% -107.53%
EBIT Q/Q Growth
-7,500.00% 139.21% -42.95% -204.71% 171.91% -237.50% -72.41% 116.67% -4,448.00% 99.63% -1,575.00%
NOPAT Q/Q Growth
-7,500.00% 146.99% -43.20% -187.75% 178.65% -225.71% -72.41% 117.14% -4,327.22% 99.63% -1,575.00%
Net Income Q/Q Growth
-7,540.00% 131.94% -41.80% -185.92% 180.33% -218.37% -94.83% 115.93% -6,794.44% 98.26% -328.57%
EPS Q/Q Growth
-4,860.00% 130.65% -43.42% -195.35% 168.29% -239.29% -141.03% 111.70% -8,927.27% 97.84% -257.14%
Operating Cash Flow Q/Q Growth
90.59% 2,425.00% -58.06% 21.79% 30.53% 213.71% -120.31% 255.70% -5.69% 202.59% -125.36%
Free Cash Flow Firm Q/Q Growth
22.37% -3.19% -26.06% -26.66% -52.52% 175.37% 12.43% 15.47% 22.07% 32.46% -11.86%
Invested Capital Q/Q Growth
-7.84% -0.54% 1.93% -1.94% -2.49% -9.33% -0.11% -2.12% -20.82% -3.60% 2.81%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
31.75% 39.00% 34.34% 35.97% 34.26% 29.92% 29.49% 34.79% 32.40% 35.90% 29.24%
EBITDA Margin
-17.99% 11.03% 8.69% -1.54% 7.69% -1.47% -6.06% 5.32% -67.28% 5.77% -0.48%
Operating Margin
-21.70% 7.68% 4.96% -5.07% 3.87% -4.99% -9.99% 1.58% -71.14% -0.25% -4.60%
EBIT Margin
-21.70% 7.68% 4.96% -5.07% 3.87% -4.99% -9.99% 1.58% -71.14% -0.25% -4.60%
Profit (Net Income) Margin
-21.82% 6.29% 4.14% -3.48% 2.97% -3.29% -7.52% 1.14% -78.86% -1.30% -6.18%
Tax Burden Percent
100.53% 81.88% 83.53% 68.54% 76.56% 65.91% 75.33% 72.00% 110.86% 525.00% 134.33%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 16.11% 16.47% 0.00% 23.44% 0.00% 0.00% 28.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-15.26% 6.87% 4.43% -3.89% 3.38% -4.08% -7.84% 1.27% -61.15% -0.22% -4.07%
ROIC Less NNEP Spread (ROIC-NNEP)
-19.97% 6.75% 4.43% -3.84% 3.38% -3.95% -8.12% 1.27% -76.39% -0.88% -5.53%
Return on Net Nonoperating Assets (RNNOA)
-11.05% 4.16% 2.88% -2.67% 3.06% -3.38% -7.26% 1.12% -97.77% -1.20% -8.41%
Return on Equity (ROE)
-26.32% 11.03% 7.31% -6.55% 6.45% -7.46% -15.10% 2.39% -158.91% -1.42% -12.48%
Cash Return on Invested Capital (CROIC)
5.93% 8.81% 7.75% 6.23% 6.09% 12.02% 11.27% 12.75% 17.50% 11.43% 9.99%
Operating Return on Assets (OROA)
-11.82% 4.41% 2.94% -3.18% 2.50% -3.19% -6.35% 1.03% -48.32% -0.17% -3.13%
Return on Assets (ROA)
-11.88% 3.61% 2.46% -2.18% 1.92% -2.10% -4.78% 0.74% -53.56% -0.88% -4.20%
Return on Common Equity (ROCE)
-24.94% 10.41% 6.89% -6.16% 5.98% -6.91% -14.02% 2.21% -142.82% -1.26% -11.05%
Return on Equity Simple (ROE_SIMPLE)
-34.47% 0.00% -5.61% -7.39% 6.49% 0.00% -7.70% -4.40% -104.22% 0.00% -123.27%
Net Operating Profit after Tax (NOPAT)
-266 125 71 -62 49 -62 -105 18 -761 -2.80 -47
NOPAT Margin
-15.19% 6.44% 4.14% -3.55% 2.97% -3.49% -6.99% 1.14% -49.80% -0.17% -3.22%
Net Nonoperating Expense Percent (NNEP)
4.71% 0.12% 0.00% -0.05% 0.00% -0.13% 0.28% 0.00% 15.24% 0.65% 1.46%
Return On Investment Capital (ROIC_SIMPLE)
- 1.77% - - - -1.06% - - - -0.06% -1.08%
Cost of Revenue to Revenue
68.25% 61.00% 65.66% 64.03% 65.74% 70.09% 70.51% 65.21% 67.60% 64.10% 70.76%
SG&A Expenses to Revenue
23.87% 22.05% 23.73% 24.69% 25.18% 24.93% 26.43% 24.90% 24.21% 23.37% 25.94%
R&D to Revenue
4.17% 3.55% 3.73% 3.25% 3.15% 3.17% 3.26% 3.17% 2.95% 2.91% 2.88%
Operating Expenses to Revenue
53.46% 31.32% 29.39% 41.05% 30.39% 34.90% 39.48% 33.21% 103.53% 36.14% 33.84%
Earnings before Interest and Taxes (EBIT)
-380 149 85 -89 64 -88 -150 25 -1,087 -4.00 -67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-315 214 149 -27 127 -26 -91 84 -1,028 93 -7.00
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.56 0.58 0.64 0.65 0.82 0.81 0.91 0.61 0.99 0.97 0.57
Price to Tangible Book Value (P/TBV)
6.61 6.20 5.46 4.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.26 0.27 0.31 0.31 0.32 0.30 0.32 0.22 0.20 0.17 0.10
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 14.80 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
8.59% 7.97% 7.05% 7.16% 6.85% 5.95% 5.70% 8.61% 9.63% 11.86% 18.12%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 6.76% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.77 0.78 0.81 0.81 0.92 0.91 0.96 0.83 1.00 0.99 0.89
Enterprise Value to Revenue (EV/Rev)
0.70 0.69 0.72 0.71 0.79 0.73 0.79 0.69 0.67 0.66 0.61
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 46.31 241.11 12.10 22.68 0.00 47.76 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 26.81 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 30.46 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
28.43 30.62 30.06 14.43 11.60 7.37 10.00 8.06 7.78 8.02 7.58
Enterprise Value to Free Cash Flow (EV/FCFF)
11.87 8.29 9.92 12.43 14.86 7.14 7.89 6.04 4.70 7.43 7.78
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.08 1.04 0.89 0.86 1.19 1.18 1.39 1.28 2.14 2.61 2.57
Long-Term Debt to Equity
0.77 0.80 0.74 0.62 0.91 0.98 1.23 1.23 1.80 2.16 2.11
Financial Leverage
0.55 0.62 0.65 0.69 0.91 0.86 0.89 0.88 1.28 1.37 1.52
Leverage Ratio
2.87 3.00 2.98 2.96 3.36 3.39 3.34 3.23 4.12 4.51 4.68
Compound Leverage Factor
2.87 3.00 2.98 2.96 3.36 3.39 3.34 3.23 4.12 4.51 4.68
Debt to Total Capital
51.85% 51.02% 47.04% 46.29% 54.43% 54.17% 58.14% 56.06% 68.12% 72.27% 72.02%
Short-Term Debt to Total Capital
14.81% 11.78% 7.93% 13.24% 13.12% 9.37% 6.53% 2.19% 10.81% 12.44% 13.08%
Long-Term Debt to Total Capital
37.04% 39.24% 39.11% 33.05% 41.31% 44.80% 51.61% 53.87% 57.31% 59.83% 58.94%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.25% 3.20% 3.33% 3.45% 3.51% 3.87% 3.50% 3.87% 4.75% 4.85% 4.98%
Common Equity to Total Capital
44.89% 45.78% 49.63% 50.27% 42.06% 41.96% 38.36% 40.07% 27.13% 22.88% 23.00%
Debt to EBITDA
-4.17 -67.75 29.54 148.38 7.79 14.70 -212.00 35.14 -3.08 -3.61 -3.84
Net Debt to EBITDA
-3.13 -48.75 24.22 125.67 6.65 12.37 -171.71 29.98 -2.59 -3.00 -3.45
Long-Term Debt to EBITDA
-2.98 -52.11 24.56 105.95 5.92 12.15 -188.18 33.77 -2.59 -2.99 -3.15
Debt to NOPAT
-4.53 -16.38 -31.02 -18.94 19.61 -167.19 -19.58 -31.67 -3.59 -3.99 -4.16
Net Debt to NOPAT
-3.40 -11.78 -25.43 -16.04 16.72 -140.71 -15.86 -27.02 -3.02 -3.32 -3.73
Long-Term Debt to NOPAT
-3.23 -12.60 -25.79 -13.53 14.89 -138.27 -17.38 -30.43 -3.02 -3.31 -3.40
Altman Z-Score
1.31 1.51 1.59 1.56 1.60 1.57 1.59 1.66 1.14 1.46 1.39
Noncontrolling Interest Sharing Ratio
5.24% 5.64% 5.69% 6.02% 7.20% 7.37% 7.14% 7.41% 10.13% 11.33% 11.48%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.17 1.23 1.26 1.15 1.12 1.14 1.37 1.49 1.26 1.12 1.09
Quick Ratio
0.85 0.92 0.88 0.81 0.80 0.82 0.98 1.03 0.86 0.77 0.67
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
971 940 695 510 242 666 750 866 1,057 1,400 1,234
Operating Cash Flow to CapEx
-80.00% 1,033.33% 975.00% 1,357.14% 1,033.33% 3,890.00% -790.00% 1,537.50% 1,288.89% 2,064.71% -445.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.54 0.57 0.59 0.63 0.65 0.64 0.64 0.65 0.68 0.68 0.68
Accounts Receivable Turnover
8.05 8.49 8.80 8.16 8.24 8.07 8.02 7.43 7.49 7.56 7.42
Inventory Turnover
5.89 6.27 5.85 5.98 6.01 6.27 5.47 5.64 5.79 6.13 5.25
Fixed Asset Turnover
0.00 20.96 21.65 23.29 24.02 23.50 24.00 25.58 25.59 24.07 28.07
Accounts Payable Turnover
4.11 3.90 3.76 4.12 4.03 3.85 3.73 4.33 4.39 4.02 3.81
Days Sales Outstanding (DSO)
45.37 43.01 41.45 44.73 44.32 45.24 45.51 49.16 48.71 48.29 49.20
Days Inventory Outstanding (DIO)
61.98 58.21 62.34 61.00 60.78 58.20 66.70 64.76 63.02 59.56 69.52
Days Payable Outstanding (DPO)
88.91 93.57 97.09 88.65 90.62 94.80 97.90 84.28 83.14 90.79 95.78
Cash Conversion Cycle (CCC)
18.44 7.65 6.71 17.08 14.48 8.64 14.31 29.63 28.60 17.06 22.93
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,292 6,258 6,379 6,255 6,099 5,530 5,524 5,407 4,281 4,127 4,243
Invested Capital Turnover
1.00 1.07 1.07 1.09 1.14 1.17 1.12 1.11 1.23 1.29 1.26
Increase / (Decrease) in Invested Capital
-1,237 -815 -624 -572 -193 -728 -855 -848 -1,818 -1,403 -1,281
Enterprise Value (EV)
4,861 4,868 5,140 5,063 5,604 5,057 5,291 4,489 4,269 4,099 3,795
Market Capitalization
1,812 1,953 2,220 2,192 2,294 2,065 2,155 1,443 1,291 1,048 605
Book Value per Share
$20.85 $21.48 $22.11 $21.56 $17.75 $20.65 $19.15 $19.01 $10.48 $8.65 $8.41
Tangible Book Value per Share
$1.76 $2.02 $2.60 $2.80 ($0.70) ($3.14) ($4.08) ($4.13) ($4.46) ($8.82) ($9.01)
Total Capital
7,224 7,303 6,970 6,732 6,631 6,049 6,199 5,892 4,802 4,703 4,579
Total Debt
3,746 3,726 3,279 3,116 3,609 3,277 3,604 3,303 3,271 3,399 3,298
Total Long-Term Debt
2,676 2,866 2,726 2,225 2,739 2,710 3,199 3,174 2,752 2,814 2,699
Net Debt
2,814 2,681 2,688 2,639 3,077 2,758 2,919 2,818 2,750 2,823 2,962
Capital Expenditures (CapEx)
10 18 8.00 7.00 12 10 10 8.00 9.00 17 20
Debt-free, Cash-free Net Working Capital (DFCFNWC)
690 592 723 855 686 446 630 649 616 325 491
Debt-free Net Working Capital (DFNWC)
1,622 1,637 1,314 1,332 1,218 965 1,315 1,134 1,137 901 827
Net Working Capital (NWC)
552 777 761 441 348 398 910 1,005 618 316 228
Net Nonoperating Expense (NNE)
116 3.00 0.00 -1.30 0.00 -3.60 8.00 0.00 444 18 43
Net Nonoperating Obligations (NNO)
2,814 2,681 2,688 2,639 3,077 2,758 2,929 2,818 2,750 2,823 2,962
Total Depreciation and Amortization (D&A)
65 65 64 62 63 62 59 59 59 97 60
Debt-free, Cash-free Net Working Capital to Revenue
9.94% 8.33% 10.11% 11.94% 9.71% 6.48% 9.44% 9.99% 9.67% 5.22% 7.95%
Debt-free Net Working Capital to Revenue
23.36% 23.03% 18.37% 18.60% 17.25% 14.01% 19.71% 17.45% 17.84% 14.48% 13.39%
Net Working Capital to Revenue
7.95% 10.93% 10.64% 6.16% 4.93% 5.78% 13.64% 15.47% 9.70% 5.08% 3.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($2.48) $0.76 $0.43 ($0.41) $0.29 ($0.40) ($0.94) $0.12 ($9.71) ($0.22) ($0.75)
Adjusted Weighted Average Basic Shares Outstanding
155.60M 156.43M 156.96M 157.12M 122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M
Adjusted Diluted Earnings per Share
($2.48) $0.76 $0.43 ($0.41) $0.28 ($0.39) ($0.94) $0.11 ($9.71) ($0.21) ($0.75)
Adjusted Weighted Average Diluted Shares Outstanding
155.60M 156.43M 156.96M 157.12M 122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
155.60M 156.43M 156.96M 157.12M 122.91M 124.18M 124.20M 124.33M 124.37M 125.28M 125.79M
Normalized Net Operating Profit after Tax (NOPAT)
38 145 73 -46 57 31 -78 27 19 0.70 -48
Normalized NOPAT Margin
2.16% 7.48% 4.24% -2.63% 3.43% 1.75% -5.17% 1.69% 1.24% 0.04% -3.27%
Pre Tax Income Margin
-21.70% 7.68% 4.96% -5.07% 3.87% -4.99% -9.99% 1.58% -71.14% -0.25% -4.60%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-16.10% -54.04% -89.18% -69.60% 96.13% 16,500.00% -85.79% -142.31% -10.38% -10.67% -11.02%
Augmented Payout Ratio
-60.91% -89.13% -89.18% -69.60% 396.69% 70,900.00% -384.70% -668.27% -10.60% -11.28% -11.40%

Key Financial Trends

Xerox Holdings Corp has experienced a notable shift in financial performance and position over the past several quarters through Q1 2025. Here's a summary of key trends and financial highlights from the latest data:

  • Operating revenue showed resilience with over $1.45 billion reported in Q1 2025; though slightly down from $1.61 billion in Q4 2024, it maintains a strong top-line presence amidst fluctuating business conditions.
  • Gross profit remains positive, with $426 million in Q1 2025, indicating effective control over cost of revenue despite tighter operating income margins.
  • Depreciation expense has increased, reflecting ongoing investment in property, plant, and equipment, which could support future capacity and modernization efforts.
  • Xerox holds a solid cash and equivalents position at $336 million as of Q1 2025, supporting liquidity and operational flexibility.
  • The company continues to manage sizable note and lease receivables ($626 million current and over $1 billion noncurrent), which is typical in its industry but warrants monitoring for collection risks.
  • Total assets stand at approximately $8.2 billion in Q1 2025, down from over $11 billion levels in early 2023 largely due to divestitures and asset disposals, suggesting a streamlined asset base.
  • Total liabilities decreased to about $6.9 billion from higher historical levels, with a long-term debt balance near $2.7 billion, reflecting continued debt management efforts.
  • The company reported a consolidated net loss of $90 million in Q1 2025, increasing from smaller losses in Q4 2024, signaling ongoing profitability challenges.
  • Operating income was negative $67 million in Q1 2025 after positive contributions in earlier quarters, highlighting margin pressures from increased operating expenses and restructuring charges.
  • Significant impairment and restructuring charges were recorded in previous quarters (e.g., over $1 billion impairment in Q3 2024), which have weighed heavily on net income and shareholders’ equity.

In summary, Xerox is navigating a challenging operating environment with shrinking profitability and elevated charges, but maintains solid revenue streams and liquidity. The company appears to be actively restructuring and managing its balance sheet to adapt, though sustaining profitability remains a key focus for upcoming periods.

08/31/25 09:05 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Xerox's Financials

When does Xerox's financial year end?

According to the most recent income statement we have on file, Xerox's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Xerox's net income changed over the last 7 years?

Xerox's net income appears to be on a downward trend, with a most recent value of -$1.32 billion in 2024, falling from $207 million in 2017. The previous period was $1 million in 2023. See where experts think Xerox is headed by visiting Xerox's forecast page.

What is Xerox's operating income?
Xerox's total operating income in 2024 was -$1.22 billion, based on the following breakdown:
  • Total Gross Profit: $2.07 billion
  • Total Operating Expenses: $3.28 billion
How has Xerox's revenue changed over the last 7 years?

Over the last 7 years, Xerox's total revenue changed from $9.99 billion in 2017 to $6.22 billion in 2024, a change of -37.7%.

How much debt does Xerox have?

Xerox's total liabilities were at $7.06 billion at the end of 2024, a 2.4% decrease from 2023, and a 63.3% decrease since 2018.

How much cash does Xerox have?

In the past 6 years, Xerox's cash and equivalents has ranged from $519 million in 2023 to $5.48 billion in 2019, and is currently $576 million as of their latest financial filing in 2024.

How has Xerox's book value per share changed over the last 7 years?

Over the last 7 years, Xerox's book value per share changed from 0.00 in 2017 to 8.65 in 2024, a change of 865.1%.



This page (NYSE:XRX) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners